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Case presentation
We describe a 19-year-old man with transposition of the great arteries, which had been corrected 14 years earlier (Senning procedure), who experienced recurrent tachycardia with incomplete right bundle branch block QRS morphology. Since the QRS morphology was identical to that during sinus rhythm and typical of patients with transposition of the great arteries (prominent features of right ventricular hypertrophy), he was presumptively diagnosed with supraventricular tachycardia ( Figure 1 ). Complex cardiosurgical operations involving atrial tissue predispose to the occurrence of intraatrial reentry due to iatrogenic scars. [1] In the current case, however, the electrophysiological study resulted in a diagnosis of atrioventricular reentrant tachycardia (AVNRT) - Figure 2 , panel A. The tachycardia had a cycle length of 380-520 ms, and a ventriculo-atrial interval of 60 ms was observed. Moreover, there was a V-A-V response to ventricular overdrive pacing, and the post-pacing interval was 158 ms longer than the tachycardia cycle length. With the support of a 3D system (EnSite NavX St. Jude Medical, Inc., St. Paul, MN, USA) we first tried to ablate the AVNRT substrate in the venous atrium near the His bundle potential with access via the inferior vena cava (Figure 2 
Commentary
Supraventricular cardiac arrhythmias significantly contribute to morbidity and mortality in patients after Senning or Mustard operations.
[2] The most commonly diagnosed arrhythmia is intraatrial reentrant tachycardia (atypical atrial flutter or micro/macro reentrant atrial tachycardia) occurring in approximately 30% of patients in long-term follow-up. [2 3] However, AVNRT should also be high on the list of possible diagnoses, as in the published short series of patients after Senning or Mustard operations who have undergone electrophysiological study for supraventricular tachycardia AVNRT was identified in 3 of 11 patients (27%) in the series of Kanter et al., [4] 4 of 34 (12%) in the study of Wu et al., [5] while Greene et al. reported AVNRT in 4 of 18 patients (22%), [6] -with the remaining patients from these series diagnosed with intraatrial reentry. Despite being supraventricular, these arrhythmias may cause acute cardiac failure or sudden cardiac death due to the fast ventricular response. [2] There are very limited data on AVNRT ablation in patients with transposition of the great arteries who have undergone the Senning operation, making the optimal approach for this procedure difficult to determine. Access to the typical anatomical location of the slow pathway via the classical route (i.e. via the inferior vena cava to the right atrium) is usually impossible because, in the Senning operation, this part of the right atrium is surgically sequestered from the anatomical/venous right atrium and used to redirect blood from the pulmonary veins to the systemic ventricle (anatomic right ventricle). Therefore ablation of AVNRT in a patient who has undergone the Senning/Mustard operation requires non-standard approaches. Three access options can be considered in order to modify atrioventricular node physiology: 1/ access to the systemic venous atrium; 2/ the transbaffle approach to the triangle of Koch, and 3/ the retrograde aortic approach. In the experience of Greene et al., access via the femoral vein to the systemic venous atrium despite induction of junctional tachycardia during ablation is not successful in eliminating AVNRT; we also failed using this approach. Venous access can be successful when it is combined with a transbaffle access, although this requires either a baffle leak or a rather invasive strategy with a baffle puncture. [7, 8] In contrast, retrograde aortic access is relatively easy and, judging by the current case and the published series (albeit mainly in patients after the Mustard procedure), often results in a curative ablation.
In conclusion, the transaortic retrograde approach to the remnant of the anatomically right atrium should be the initially preferred slow pathway ablation strategy in patients after the Senning procedure.
